Bayer expands biologicals portfolio in Latin America

Bayer is launching a new umbrella brand, Biológicos Bayer, to consolidate its biological solutions across Latin America. The company plans to release 17 new products in the region by 2030, with eight of those launches specifically targeting the Brazilian market.

To support this expansion, Bayer has entered a partnership with the Brazilian company IdeeLab to co-develop a biofungicide tailored for tropical agriculture. This collaboration aims to address the specific needs of tropical farmers, which differ from those in Europe and the United States. The development process is expected to take approximately 12 months, with initial commercialization starting in Brazil.

Bayer currently holds 45 biological products in Latin America, though only three are presently available in Brazil. The company views biologicals as essential components of regenerative agriculture that complement chemical pesticides. This strategic move comes as the global biologicals market is projected to grow at an annual rate of approximately 8% through 2035.